Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose glucocorticoids pulse-therapy for beta-coronaviridae pneumonia: a systematic literature review and case-series of Coronavirus disease-2019.
Dolci G, Cassone G, Venturelli F, Besutti G, Revelli M, Corsini R, Sampaolesi F, Pavone P, Contardi G, Riva N, Marini G, Lazzaretti C, Mezzadri S, Milic J, Massari M, Costantini M, Salvarani C. Dolci G, et al. Among authors: lazzaretti c. Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1119-1125. doi: 10.55563/clinexprheumatol/36rs0j. Epub 2021 Feb 26. Clin Exp Rheumatol. 2021. PMID: 33635218 Free article.
May 2020: Is It Always COVID-19 No Matter What?
Livrieri F, Ghidoni G, Piro R, Menzella F, Cavazza A, Lazzaretti C, Massari M, Montanari G, Fontana M, Facciolongo NC. Livrieri F, et al. Among authors: lazzaretti c. Int Med Case Rep J. 2020 Nov 2;13:563-567. doi: 10.2147/IMCRJ.S277474. eCollection 2020. Int Med Case Rep J. 2020. PMID: 33173352 Free PMC article.
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation.
Mussini C, Giacomelli A, Quiros-Roldan E, Mazzotta V, Di Biagio A, De Vito A, Costantini A, D'Ettorre G, Giacometti A, Vergori A, Tavelli A, Malagnino V, Castagna A, Chester J, Antinori A, d'Arminio Monforte A, Cozzi-Lepri A; Icona Foundation Cohort Study for the Icona Foundation Study Group. Mussini C, et al. EClinicalMedicine. 2025 Jul 24;86:103368. doi: 10.1016/j.eclinm.2025.103368. eCollection 2025 Aug. EClinicalMedicine. 2025. PMID: 40740293 Free PMC article.
Decrease in Incidence Rate of Hospitalizations Due to AIDS-Defining Conditions but Not to Non-AIDS Conditions in PLWHIV on cART in 2008-2018 in Italy.
Nozza S, Timelli L, Saracino A, Gianotti N, Lazzaretti C, Tavelli A, Puoti M, Lo Caputo S, Antinori A, Monforte AD, Mussini C, Girardi E, On Behalf Of Icona Foundation Study Group. Nozza S, et al. Among authors: lazzaretti c. J Clin Med. 2021 Jul 30;10(15):3391. doi: 10.3390/jcm10153391. J Clin Med. 2021. PMID: 34362172 Free PMC article.
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort.
d'Arminio Monforte A, Tavelli A, Di Biagio A, Sarmati L, Marchetti GC, Bai F, Cingolani A, Quiros Roldan E, Mussini C, Lichtner M, Vergori A, Piconi S, Orofino G, Fusco FM, Bandera A, Nozza S, Castagna A, Antinori A; ICONA Foundation Study Group. d'Arminio Monforte A, et al. J Antimicrob Chemother. 2024 Jun 3;79(6):1279-1288. doi: 10.1093/jac/dkae081. J Antimicrob Chemother. 2024. PMID: 38581349 Free article.
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort.
Vergori A, Cozzi-Lepri A, Lo Caputo S, Tavelli A, Mazzotta V, Schiaroli E, Orofino G, Mussini C, Nozza S, Cingolani A, Antinori A, d'Arminio Monforte A; Icona Foundation Study Group. Vergori A, et al. J Antimicrob Chemother. 2025 Nov 4;80(11):3082-3091. doi: 10.1093/jac/dkaf345. J Antimicrob Chemother. 2025. PMID: 40985146 Free PMC article.
Exploring heterogeneity in antibiotic choices for bloodstream infections caused by AmpC-producing enterobacterales: results from a case-vignette study.
Tebano G, Campoli C, Meschiari M, Contadini I, Grasselli S, Lazzaretti C, Maritati M, Raumer L, Rinaldi M, Rossi N, Scolz K, Vanino E, Mussini C, Viale P, Cristini F. Tebano G, et al. Among authors: lazzaretti c. Eur J Clin Microbiol Infect Dis. 2025 Oct 4. doi: 10.1007/s10096-025-05293-4. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2025. PMID: 41045445
65 results